Estradiol and dienogest and Mitapivat interaction

Estradiol and dienogest and Mitapivat: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Mitapivat (AQVESME) label · effective 2026-08-27

Major

Sensitive CYP3A substrates including hormonal contraceptives: Avoid concomitant use with substrates that have narrow therapeutic index.

Drug interactionsby drug classView label on DailyMed
Major

Avoid concomitant use with hormonal contraceptives except for intrauterine systems containing levonorgestrel.

Drug interactionsby drug classView label on DailyMed
Moderate

Co-administration of AQVESME will decrease systemic concentrations of drugs that are sensitive CYP3A substrates, including hormonal contraceptives (e.g., ethinyl estradiol) [see Clinical Pharmacology (12.3) ] .

Drug interactionsby drug classView label on DailyMed
No interaction

If contraception is desired or needed, use an alternative contraceptive that is not affected by enzyme inducers.

Drug interactionsby drug classView label on DailyMed

From the Estradiol and dienogest (Natazia) label · effective 2024-06-26

Moderate

Women who take medications that are strong CYP3A4 inducers should not choose Natazia as their oral contraceptive while using these inducers and for at least 28 days after discontinuation of these inducers due to the possibility of increased breakthrough bleeding and/or decreased contraceptive efficacy.

Drug interactionsby drug classView label on DailyMed
Moderate

Multiple dose co-administration of the strong CYP3A4 inducer rifampin with estradiol valerate/dienogest tablets in healthy postmenopausal women led to a decrease in dienogest and estradiol systemic exposure at steady state. [See Clinical Pharmacology (12.3).] Substances Increasing the Systemic Exposure of COCs (enzyme inhibitors): Concomitant administration of…

Drug interactionsby drug classView label on DailyMed
Minor

• CYP3A4 induction : Women taking strong CYP3A4 inducers (for example, carbamazepine, phenytoin, rifampicin, and St.

Warnings and precautionsby drug classView label on DailyMed
Minor

Drug Interactions Women who take medications that are strong cytochrome P450 3A4 (CYP3A4) inducers (for example, carbamazepine, phenytoin, rifampicin, and St.

Warnings and precautionsby drug classView label on DailyMed
Minor

Counsel patients to use a back-up or alternative method of contraception when enzyme inducers are used with COCs.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.